Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
21.79
-1.74 (-7.39%)
At close: Nov 20, 2024, 4:00 PM
22.02
+0.23 (1.06%)
Pre-market: Nov 21, 2024, 7:42 AM EST
Hims & Hers Health Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Hims & Hers Health stock have an average target of 21.54, with a low estimate of 11 and a high estimate of 28. The average target predicts a decrease of -1.15% from the current stock price of 21.79.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HIMS stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 6 | 6 | 6 | 6 |
| Buy | 2 | 1 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 6 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +28.50% | Nov 20, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $32 → $18 | Strong Buy → Sell | Downgrades | $32 → $18 | -17.39% | Nov 14, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $25 → $28 | Strong Buy | Maintains | $25 → $28 | +28.50% | Nov 8, 2024 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $23 → $27 | Hold | Maintains | $23 → $27 | +23.91% | Nov 6, 2024 |
| Piper Sandler | Piper Sandler | Hold Reiterates $18 → $21 | Hold | Reiterates | $18 → $21 | -3.63% | Nov 5, 2024 |
Financial Forecast
Revenue This Year
1.48B
from 872.00M
Increased by 69.84%
Revenue Next Year
2.05B
from 1.48B
Increased by 38.42%
EPS This Year
0.51
from -0.11
EPS Next Year
0.47
from 0.51
Decreased by -9.35%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.5B | 2.4B | 3.0B | ||
| Avg | 1.5B | 2.1B | 2.4B | ||
| Low | 1.4B | 1.7B | 1.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 77.1% | 58.9% | 44.4% | ||
| Avg | 69.8% | 38.4% | 15.9% | ||
| Low | 55.0% | 16.1% | -7.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.66 | 0.86 | 1.46 | ||
| Avg | 0.51 | 0.47 | 0.80 | ||
| Low | 0.19 | 0.18 | 0.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 67.3% | 212.9% | ||
| Avg | - | -9.4% | 72.5% | ||
| Low | - | -65.7% | -24.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.